Pages that link to "Q33353052"
Jump to navigation
Jump to search
The following pages link to AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease (Q33353052):
Displaying 50 items.
- An update of biochemical markers of hepatocellular carcinoma (Q26752700) (← links)
- Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma (Q26772321) (← links)
- Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china (Q27003291) (← links)
- Can serum glypican-3 be a biomarker for effective diagnosis of hepatocellular carcinoma? A meta-analysis of the literature (Q27023427) (← links)
- Identifying Genes for Establishing a Multigenic Test for Hepatocellular Carcinoma Surveillance in Hepatitis C Virus-Positive Cirrhotic Patients (Q27490438) (← links)
- Hepatoprotective effect of ethanolic extract of Curcuma longa on thioacetamide induced liver cirrhosis in rats. (Q31112943) (← links)
- A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease (Q33490839) (← links)
- Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1. (Q33509293) (← links)
- Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma (Q33643368) (← links)
- Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinoma (Q33753952) (← links)
- Y-box protein-1/p18 fragment identifies malignancies in patients with chronic liver disease (Q33906226) (← links)
- High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma. (Q33966440) (← links)
- Association between serum alpha-fetoprotein levels and fatty liver disease: a cross-sectional study (Q34137427) (← links)
- Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy (Q34256150) (← links)
- Activins and follistatins: Emerging roles in liver physiology and cancer (Q34391497) (← links)
- A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis (Q34762279) (← links)
- Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma (Q35960878) (← links)
- Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again (Q36082480) (← links)
- Efficacy of Boesenbergia rotunda Treatment against Thioacetamide-Induced Liver Cirrhosis in a Rat Model (Q36228792) (← links)
- Des-γ-Carboxyprothrombin Plasma Level in Diagnosis of Hepatocellular Carcinoma in a Chinese Population Undergoing Surgery. (Q37020982) (← links)
- Frequency of elevated biomarkers in patients with cryptogenic hepatocellular carcinoma (Q37178560) (← links)
- A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular Carcinoma (Q37206392) (← links)
- Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients. (Q37330554) (← links)
- Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis (Q37343300) (← links)
- Perspectives on using des-γ-carboxyprothrombin (DCP) as a serum biomarker: facilitating early detection of hepatocellular carcinoma in China (Q37584690) (← links)
- Combining multiple serum biomarkers in tumor diagnosis: A clinical assessment (Q37641050) (← links)
- Effects of two genes coding squamous cell carcinoma antigen on the diagnosis and treatment of cervical squamous cell carcinoma. (Q37721997) (← links)
- Clinical and molecular insights into the hepatocellular carcinoma tumour marker des‐γ‐carboxyprothrombin (Q37793324) (← links)
- Diagnostic accuracy of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatocellular carcinoma: A systematic review (Q38120063) (← links)
- Serum protein biomarkers relevant to hepatocellular carcinoma and their detection (Q38647536) (← links)
- Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysis (Q38985923) (← links)
- Glypican-3-Expressing Hepatocellular Carcinoma in a Non-Cirrhotic Patient with Nonalcoholic Steatohepatitis: Case Report and Literature Review (Q39036903) (← links)
- An Easy and Useful Noninvasive Score Based on α-1-acid Glycoprotein and C-Reactive Protein for Diagnosis of Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus Infection (Q39324590) (← links)
- Prognotic impact of serum follistatin in patients with hepatocellular carcinoma (Q39463161) (← links)
- Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients (Q39734652) (← links)
- Glypican 3 as a Serum Marker for Hepatoblastoma (Q42003901) (← links)
- Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population (Q42278956) (← links)
- N-glycan based models improve diagnostic efficacies in hepatitis B virus-related hepatocellular carcinoma (Q43244550) (← links)
- Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study (Q45465312) (← links)
- BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration. (Q47237512) (← links)
- Current status and future prospects of biomarkers in the diagnosis of hepatocellular carcinoma. (Q47920503) (← links)
- SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study. (Q50551137) (← links)
- A quantitative analytical method for PIVKA-II using multiple reaction monitoring-mass spectrometry for early diagnosis of hepatocellular carcinoma (Q51014907) (← links)
- AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues (Q51612333) (← links)
- Liver Cancer in Tyrosinemia Type 1. (Q51817708) (← links)
- Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma. (Q53794062) (← links)
- Duration of hepatic vascular inflow clamping and survival after liver resection for hepatocellular carcinoma (Q84248079) (← links)
- Dynamic Changes in Serum Markers and Their Utility in the Early Diagnosis of All Stages of Hepatitis B-Associated Hepatocellular Carcinoma (Q89867713) (← links)
- Usefulness of plasma full-length glypican-3 as a predictive marker of hepatocellular carcinoma recurrence after radial surgery (Q90697929) (← links)
- SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy (Q92138199) (← links)